Literature DB >> 2897123

Molecular cloning of human T-cell lymphotrophic virus type I-like proviral genome from the peripheral lymphocyte DNA of a patient with chronic neurologic disorders.

E P Reddy1, R V Mettus, E DeFreitas, Z Wroblewska, M Cisco, H Koprowski.   

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-I), the etiologic agent of human T-cell leukemia, has recently been shown to be associated with neurologic disorders such as tropical spastic paraparesis, HTLV-associated myelopathy, and possibly with multiple sclerosis. In this communication, we have examined one specific case of neurologic disorder that can be classified as multiple sclerosis or tropical spastic paraparesis. The patient suffering from chronic neurologic disorder was found to contain antibodies to HTLV-I envelope and gag proteins in his serum and cerebrospinal fluid. Lymphocytes from peripheral blood and cerebrospinal fluid of the patient were shown to express viral RNA sequences by in situ hybridization. Southern blot analysis of the patient lymphocyte DNA revealed the presence of HTLV-I-related sequences. Blot-hybridization analysis of the RNA from fresh peripheral lymphocytes stimulated with interleukin 2 revealed the presence of abundant amounts of genomic viral RNA with little or no subgenomic RNA. We have cloned the proviral genome from the DNA of the peripheral lymphocytes and determined its restriction map. This analysis shows that this proviral genome is very similar if not identical to that of the prototype HTLV-I genome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897123      PMCID: PMC280261          DOI: 10.1073/pnas.85.10.3599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.

Authors:  S Matsushita; M Robert-Guroff; J Trepel; J Cossman; H Mitsuya; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  HTLV-I infection of cerebrospinal fluid T cells from patients with chronic neurologic disease.

Authors:  E DeFreitas; Z Wroblewska; G Maul; W Sheremata; P Ferrante; E Lavi; M Harper; F di Marzo-Veronese; H Koprowski
Journal:  AIDS Res Hum Retroviruses       Date:  1987       Impact factor: 2.205

6.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

7.  HTLV-I and HTLV-III antibodies and tropical spastic paraparesis.

Authors:  P Rodgers-Johnson; D C Gajdusek; O S Morgan; V Zaninovic; P S Sarin; D S Graham
Journal:  Lancet       Date:  1985-11-30       Impact factor: 79.321

8.  A transgenic mouse model for human neurofibromatosis.

Authors:  S H Hinrichs; M Nerenberg; R K Reynolds; G Khoury; G Jay
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

9.  HTLV-I and chronic nervous diseases: present status and a look into the future.

Authors:  H Koprowski; E DeFreitas
Journal:  Ann Neurol       Date:  1988       Impact factor: 10.422

10.  Multiple sclerosis and human T-cell lymphotropic retroviruses.

Authors:  H Koprowski; E C DeFreitas; M E Harper; M Sandberg-Wollheim; W A Sheremata; M Robert-Guroff; C W Saxinger; M B Feinberg; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1985 Nov 14-20       Impact factor: 49.962

View more
  7 in total

1.  The cellular proto-oncogene product Myb acts as transcriptional activator of the long terminal repeat of human T-lymphotropic virus type I.

Authors:  P Dasgupta; C D Reddy; P Saikumar; E P Reddy
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

2.  Purification and characterization of multiple nuclear factors that bind to the TAX-inducible enhancer within the human T-cell leukemia virus type 1 long terminal repeat.

Authors:  T H Tan; M Horikoshi; R G Roeder
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

3.  Chromosomal translocation in T-cell leukemia line HUT 78 results in a MYC fusion transcript.

Authors:  L R Finger; K Huebner; L A Cannizzaro; K McLeod; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 4.  The myeloneuropathies of Jamaica.

Authors:  O St Clair Morgan
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

5.  Utilization of signal transduction pathway by the human T-cell leukemia virus type I transcriptional activator tax.

Authors:  T H Tan; R Jia; R G Roeder
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

6.  Enzymatic amplification of exogenous and endogenous retroviral sequences from DNA of patients with tropical spastic paraparesis.

Authors:  C R Bangham; S Daenke; R E Phillips; J K Cruickshank; J I Bell
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

7.  Amplification of HTLV-1-related sequences among patients with neurological disorders in highly endemic Nagasaki: lack of evidence for association of HTLV-1 with multiple sclerosis.

Authors:  D Nakayama; S Katamine; H Kanazawa; N Shibuya; K Kawase; R Moriuchi; T Miyamoto; S Hino
Journal:  Jpn J Cancer Res       Date:  1990-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.